瑞典帕瑞医学Perimed AB www.perimed.com.cn www.perimed-instruments.com
瑞典Perimed AB是世界上最早研究医用激光多普勒技术和开发医用激光多普勒仪的专业公司,总部设在瑞典首都斯德哥尔摩。瑞典Perimed公司从1981年开始专业研制、生产和推广用于监测微循环灌注量的激光多普勒仪。目前,Perimed在欧洲、美国和中国设有子公司,并在三十多个国家设有总代理,产品广泛应用于世界各大医学研究中心、临床医院和药物研究所。1984年,Perimed激光多普勒仪首次销往中国。从此,我们开始了与中国的科学家和医学家们的愉快合作。 瑞典Perimed医疗器械中国有限公司致力于将国外最先进的激光多普勒技术和相关的医疗产品带到中国,为中国医疗事业的发展贡献力量。因此,我们愿意尽最大的努力为您提供高质量的设备、培训和应用技术上的支持。 帕瑞医学——微循环领域的最佳伙伴!
激光多普勒血流仪、激光多普勒及经皮氧分压监测系统、激光多普勒血流灌注成像系统、经皮血气监测仪、离子导入仪、循序减压袜(弹力袜)、精细化工品等
帕瑞医学(中国)
北京市朝阳区大屯路慧忠北里311号楼天创世缘B1座2104室,100012
电话:+86-10-64125885
传真:+86-10-64808644
免费客服:400-669-6040
电邮: info@perimed.com.cn
To improve the quality of life for people suffering from vascular diseases, Perimed provides instruments, software and expertise for precise and convenient measurement of vascular function and diseases.
Perimed AB, established in 1981 and headquartered just outside Stockholm, is the world leader in developing, manufacturing and marketing state-of-the-art equipment for microvascular diagnosis. With customers in more than 80 countries, Perimed also actively participates in a wide range of research projects together with leading universities to deepen our understanding of diseases related to blood perfusion and microvascular functions. Knowledge gained is continually re-invested in further development.
Perimed has subsidiaries in the UK, United States, France, Italy, Mainland China and Hong Kong. Customers and sales leads in other countries are either supported by local representatives or directly from the company’s headquarters. Perimed’s policy and ambition are that all researchers and clinicians shall be offered expert help to select the optimum equipment for their application, followed by thorough after-sales training in Sweden. Training includes teaching in microcirculation, physiology and use of the equipment to achieve optimum results in the shortest time. After so many years of experience in the microcirculation field, we have a broad knowledge in most applications in animal research as well as in clinical work.